H.C. Wainwright Downgrades aTyr Pharma (ATYR) to Neutral
Tweet Send to a Friend
H.C. Wainwright analyst Joseph Pantginis downgraded aTyr Pharma (NASDAQ: ATYR) from Buy to Neutral.The analyst comments "Phase 3 EFZO-FIT misses ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
